VEGFA and age-related macular degeneration: Aflibercept (originally called VEGF-Trap) was approved in August of 2012 under the trade name of Zaltrap for the treatment of metastatic colon cancer, and the same molecule was approved in November of 2011 under the trade name of Eylea for the treatment of AMD.